Merge shareholders are slated to receive $7.13 per share in cash as the transaction closes, the Armonk, N.Y.-based company said.
IBM said it will combine the newly purchased assets, including data and images from Merge Healthcare’s medical imaging management platform with its Watson Health analytics unit.
Cloud-based Watson computing system analyzes high volumes of data, understands complex questions posed in natural language and proposes evidence-based answers.
The deal is IBM’s 3rd major health-related buy since launching its Watson Health unit in April.
The transaction was 1st announced in August.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.